Allergan Says FDA Accepts Its NDA Filing Of Oxymetazoline HCI Cream 1.0%
May 24, 2016 at 08:26 AM EDT
Allergan plc (NYSE: AGN) revealed Tuesday that the FDA has accepted its New Drug Application (NDA) filing for its oxymetazoline HCl ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.